Development of potent and selective ENPP1 inhibitors based on imidazo[1,2-a]pyrazine and pyrazine scaffolds for cancer immunotherapy

This publication has 37 references indexed in Scilit:

• cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors
  Cellular and Molecular Life Sciences, 2024
• Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects
  European Journal of Medicinal Chemistry, 2024
• Immunotherapy for Head and Neck Cancer
  2023
• Discovery of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one and 3,4-dihydropyrido[2,3-d]pyrimidin-2(1H)-one derivatives as novel ENPP1 inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2022
• Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents
  European Journal of Medicinal Chemistry, 2021
• Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway
  Acta Pharmaceutica Sinica B, 2020
• STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease
  Cell Host & Microbe, 2015
• The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STING
  Cell Reports, 2013
• The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade
  Clinical Neurology and Neurosurgery, 2011
• Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion
  Cell and tissue research, 2002